{
    "2021-12-29": [
        [
            {
                "time": "",
                "original_text": "医药行业投资策略：关注政策扰动下的个股机会",
                "features": {
                    "keywords": [
                        "医药",
                        "投资策略",
                        "政策",
                        "个股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德现1笔大宗交易，共成交443.64万元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "北上资金今日净买入宁德时代6.17亿元、泸州老窖3.58亿元，净卖出招商银行8.60亿元、药明康德4.79亿元。",
                "features": {
                    "keywords": [
                        "北上资金",
                        "净买入",
                        "净卖出",
                        "宁德时代",
                        "药明康德"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "金融",
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德今日大宗交易成交3.96万股，成交价112.03元折价6.01%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易",
                        "折价"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "北向资金年末交投持续低迷净买入逾6亿元，连续4日加仓宁德时代累计扫货超20亿",
                "features": {
                    "keywords": [
                        "北向资金",
                        "低迷",
                        "净买入",
                        "宁德时代"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "小摩减持药明康德138.398万股，每股作价约132.78港元减持股份",
                "features": {
                    "keywords": [
                        "小摩",
                        "减持",
                        "药明康德"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "西南证券医药2022年度策略：未来医药估值有望均衡，“穿越医保”和“疫情脱敏”是两条核心主线",
                "features": {
                    "keywords": [
                        "西南证券",
                        "医药",
                        "估值",
                        "穿越医保",
                        "疫情脱敏"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物：关注年报业绩预告有望高增长公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "年报",
                        "业绩预告",
                        "高增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "安信国际 | 医药行业：关注中药消费品优质个股",
                "features": {
                    "keywords": [
                        "安信国际",
                        "医药",
                        "中药消费品",
                        "优质个股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "开拓药业“临门”受挫股价暴跌，国产新冠口服药任重道远",
                "features": {
                    "keywords": [
                        "开拓药业",
                        "临门",
                        "受挫",
                        "股价暴跌",
                        "新冠口服药"
                    ],
                    "sentiment_score": 0.1,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}